Jan Wald analyst

Covered Stocks

Jan Wald

Work

Analyst Jan Wald is focused on the Healthcare sector with 15 price targets and ratings documented since 2013 spanning on 1 stocks. Previously, Jan Wald worked at BENCHMARK. Analyst's average stock valuation to be materialised ratio is 100% with an average time for price targets to be met of 367 days.

Most recent stock forecast was given on EXAS, Exact Sciences Corporation at 26-Oct-2016.

Jan Wald best performing recommendations are on EXAS (EXACT SCIENCES CORPORATION).
The best stock recommendation documented was for EXAS (EXACT SCIENCES CORPORATION) at 2/24/2016. The price target of $9 was fulfilled within 111 days with a profit of $3.13 (53.32%) receiving and performance score of 4.8.

Average potential price target upside

EXAS

Analyst name

Rating

Current price target

Potential distance

Previous price target

Date

Price targets met ratio

Average potential upside

Average time for PT to be met

Performance score

Buy

60

11 days ago

1/7 (14.29%)

$29.74 (48.24%)

63

Buy

75

$7.52 (11.14%)

95

17 days ago

18/27 (66.67%)

$22.99 (32.07%)

140

Buy

70

$2.52 (3.73%)

120

1 months 13 days ago

17/18 (94.44%)

$10.71 (20.26%)

110

Buy

65

$-2.48 (-3.68%)

85

1 months 13 days ago

7/8 (87.5%)

$10.8 (16.74%)

62

Hold

50

$-17.48 (-25.90%)

40

2 months 15 days ago

3/3 (100%)

$2.69 (5.95%)

84

Show more analysts
EXAS